Interferon-γ secretion by t(9;22) acute lymphoblastic leukemia-derived dendritic cells

Michael T Brady1, Jaewoo Lee, Soldano Ferrone

  • 1Leukemia Section, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

Leukemia Research
|October 15, 2010
PubMed

Insights

Human myeloid dendritic cells (DCs) derived from t(9;22) acute lymphoblastic leukemia (ALL) produce Interferon (IFN)-γ. This production is linked to DC maturation and is the first demonstration of IFN-γ secretion by these specific ALL-DCs.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Interferon-gamma (IFN-γ) is crucial for immune responses and anti-tumor activity.
  • While typically produced by lymphocytes, myeloid dendritic cells (DCs) also secrete IFN-γ.
  • Acute lymphoblastic leukemia (ALL)-derived DCs can elicit cytotoxic T cell responses.

Purpose of the Study:

  • To investigate whether t(9;22) ALL-derived DCs secrete IFN-γ.
  • To determine the levels of IFN-γ produced by these cells.
  • To explore the relationship between ALL-DC maturation and IFN-γ production.

Main Methods:

  • Culturing and maturation of t(9;22) ALL-derived DCs.
  • Quantification of IFN-γ secretion using established assays.
  • Analysis of IFN-γ production in relation to DC maturation status.

Main Results:

  • Interferon-gamma (IFN-γ) was detected in the supernatant of t(9;22) ALL-derived DCs.
  • IFN-γ production varied among different ALL-DC samples, with a median of 3450 pg/ml.
  • IFN-γ secretion was found to be dependent on the maturation state of the ALL-DCs.

Conclusions:

  • This study provides the first evidence of IFN-γ production by t(9;22) ALL-derived DCs.
  • The findings suggest a potential role for these DCs in modulating anti-tumor immunity.
  • ALL-DC maturation is a key factor influencing IFN-γ secretion.